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Abstrak 
PPAR merupakan faktor transkripsi yang boleh meredakan tindakbalas imun apabila diaktifkan oleh 
ligan.  Di dalam kajian ini, ekspresi isoform PPAR dan sitokin telah diukur dalam mencit model 
Diabetis jenis 1 yang dikenali sebagai mencit diabetik tanpa obes (NOD) dan spesies kawalannya 
iaitu mencit resistan diabetes tanpa obes (NOR).  Sel makrofaj peritoneal (PM) serta sel T CD4+ dan 
CD8+ dari mencit jantan NOD dan NOR yang berusia 5, 10 dan 35 minggu (usia diabetik) telah 
diperolehi untuk cerapan PCR masa sebenar dan semi-kuantitatif.  Kajian histologi juga dijalankan 
pada pankreas mencit-mencit tersebut.  PCR masa sebenar tidak menunjukkan perbezaan yang 
signifikan dalam pengekspresan PPAR-α, γ1, γ2 antara mencit NOD dan NOR pada usia 5 minggu.  
Tetapi pada usia 10 minggu, pengekspresan PPAR-α bertambah manakala PPAR-γ1 mengurang 
secara signifikan pada sel PM.  Pada usia diabetik, tidak ada pengekspresan signifikan yang dapat 
dicerap dalam semua jenis sel antara mencit NOR dan NOD diabetik kecuali PPAR-γ2, yang mana 
pengekspresannya lebih tinggi dalam sel T CD8+ mencit NOR.  Walaupun isoform PPAR 
mempunyai kesan anti-inflamasi, pengekspresannya di dalam kebanyakan sel mencit NOD tanpa 
diabetes adalah lebih rendah secara signifikan, terutamanya PPAR-γ1.  Semi-kuantifikasi PCR 
menunjukkan profil sitokin pro-inflamasi dan Th1 pada semua sel mencit muda NOD berbanding 
NOR, dengan pengekspresan IL-2, TNF-α dan IFN-γ yang signifikan.  Cerapan mencit usia diabetik 
adalah di luar jangkaan kerana pengekspresan sitokin pro-inflamasi dan Th1 adalah lebih tinggi 
secara signifikan di dalam semua sel mencit NOR berbanding NOD diabetik dan tanpa diabetes.  
Walau bagaimanapun, pengekspresan sitokin Th2 juga adalah lebih tinggi secara signifikan di 
dalam sel T CD4+ mencit NOR.  Mencit NOD tanpa diabetes mempunyai pengekspresan signifikan 
IL-2 yang lebih rendah pada sel PM serta IL-1β dan IL-12 pada sel T CD4+ berbanding mencit NOR 
dan NOD diabetik.  Kajian histologi menunjukkan pankreas yang normal dalam mencit NOR dan 
insulitis gred rendah pada mencit NOD muda dan tanpa diabetes.  Pankreas mencit NOD diabetik 
mempunyai gred insulitis yang paling tinggi.  Secara keseluruhannya, pengekspresan konstitutif 
isoform PPAR tidak menunjukkan kesan anti-inflamasi di dalam patogenesis Diabetes jenis 1 
mencit NOD jantan.  Pengekspresan sitokin pro-inflamasi dan Th1 adalah selaras dengan insulitis 
yang dicerap pada mencit NOD muda.  Kekurangan pengekspresan beberapa sitokin pro-inflamasi 
dan Th1 dalam mencit NOD tanpa diabetes mungkin menyebabkan insulitis gred rendah dan 
ketiadaan penyakit.  Bagi mencit NOR pula, pengekspresan sitokin pro-inflamasi dan Th1 yang 
rendah pada usia muda serta sitokin Th2 yang tinggi pada usia diabetik merupakan salah satu faktor 
yang boleh memberi kerentanan terhadap penyakit Diabetes jenis 1. 
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THE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) 
ISOFORMS IN THE PATHOGENESIS OF TYPE 1 DIABETES IN MALE NOD MICE  
 
Abstract 
Peroxisome Proliferator-Activated Receptor (PPAR) is a transcription factor that was observed to 
suppress the immune response when activated with ligands.  In this study, the expression of PPAR 
isoforms (PPAR-α, γ1 and γ2) and cytokines were evaluated using an animal model of autoimmune 
diabetes called the non-obese diabetic (NOD) mouse with a control strain called the non-obese 
diabetes resistant (NOR) mouse.  Peritoneal macrophages (PM), CD4+ and CD8+ T cells were 
harvested from 5, 10 and 35 week (diabetic age) male mice for real time and semi-quantitative PCR.  
Histological observations were also performed on the pancreas.  Real time PCR quantification 
revealed no significant difference between the expression of PPAR-α, γ1 and γ2 in cells of 5-week-
old mice, but in PM cells of 10-week-old mice, the expression of PPAR-α was significantly higher 
and PPAR-γ1 was significantly lower in NOD mice.  At diabetic age, no significant difference of 
expression was detected between NOR and diabetic NOD mice in all cell types except PPAR-γ2, 
which was higher in CD8 T cells of NOR mice.  Unexpected results were observed when non-
diabetic NOD mice were compared to NOR and diabetic NOD mice.  Although PPAR has an 
immune suppressive effect, most of the cell types from non-diabetic NOD mice had significantly 
lower PPAR isoform expression, especially PPAR-γ1.  Semi-quantification of cytokines in all cell 
types indicate a pro-inflammatory and Th1 profile in young NOD mice with significant IL-2, TNF-α 
and IFN-γ expression.  At diabetic age, another unexpected result was observed when the 
expression of pro-inflammatory and Th1 cytokines were significantly higher in all the cell types of 
NOR compared to diabetic and non-diabetic NOD mice.  However, the expression of Th2 cytokines 
were also significantly higher in CD4+ T cells of NOR mice.  Non-diabetic NOD mice had a 
significantly lower expression of IL-2 in PM cells and IL-1β with IL-12 in CD4+ T cells compared 
to NOR and diabetic NOD mice.  Histological studies observed normal pancreas in NOR mice, low 
grade insulitis in young and non-diabetic NOD mice and high grade insulitis in diabetic NOD mice.  
Overall, the constitutive expression of PPAR isoforms did not reflect the expected role in 
suppressing the pathogenesis of Type 1 diabetes of male NOD mice.  The pro-inflammatory and 
Th1 cytokine profile concurs with the development of insulitis in NOD mice at young age.  At 
diabetic age, the lack of some pro-inflammatory and Th1 cytokine expression in non-diabetic NOD 
mice could be one of the factors for low grade insulitis and inhibition to the onset of diabetes.  For 
NOR mice, lower expression of pro-inflammatory and Th1 cytokines at young age and high Th2 
cytokines at diabetic age correlated with disease resistance as would be expected.    
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CHAPTER 1 
INTRODUCTION 
 
1.1  Autoimmune Diseases 
Autoimmune diseases are caused by the pathogenic effect of autoantibodies or 
autoreactive T cells that provoke inflammation, functional alterations and anatomical 
lesions.  The pathogenesis are caused by defects in T and B cell selection that differ in the 
autoantigen recognized and hence, the injury of the target organ (Gorodezky et al., 2006).  
There are four criteria used to characterize an autoimmune disease (Bach, 1997, Janeway et 
al., 2001):    
 
a. The patients’ antibodies or T cells can transfer the disease. 
b. The disease course can be slowed or prevented by immunosuppressive therapy. 
c. The disease is associated with manifestations of humoral or cell mediated  
autoimmunity directed against self tissues or organs. 
d. Disease can be experimentally induced by sensitization against an autoantigen 
present in an organ or tissue, which presupposes the knowledge of the target 
autoantigen. 
 
Diseases associated with autoimmune phenomena tend to distribute within a 
spectrum.  At one pole are organ specific diseases such as Type 1 diabetes (IDDM), 
Hashimoto’s thyroiditis and Addison’s disease, where autoantibodies and chronic invasive 
inflammatory cells’ destructive lesions are directed against a single organ in the body.  On 
the other end of the spectrum are the non-organ specific autoimmunity typified by Systemic 
Lupus Erythematosus (SLE), where autoantibodies are directed to antigens throughout the 
body, resulting in immune complex mediated lesions that are widely disseminated (Kukreja 
& McLaren, 1999).  Autoimmune diseases also frequently occur at a certain age, like Type 
1 diabetes primarily occurring in childhood, myasthenia gravis and multiple sclerosis in 
midlife and rheumatoid arthritis in old age (Cooper & Stroehla, 2003).    
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The role of T cells in autoimmunity is important because T cells are involved in 
mediating the immune response to autoantigens presented by antigen presenting cells 
(APC).  Several autoimmune diseases are genetically linked to the Major 
Histocompatibility (MHC) class I and II genes for humans and mice (H-2), whose 
expressed protein molecules in antigen presenting cells (APC) bind to self-antigens to be 
presented to helper (CD4+) and cytotoxic (CD8+) T cells to induce an immune response 
(Graves & Eisenbarth, 1999).  There are multiple interacting factors that lead to the 
development of autoimmunity.  The factors include abnormalities in lymphocytes and APC, 
genes that predispose to autoimmunity, infections, tissue injury, hormone and drug 
influence (Abbas et al., 2000).  Currently, an article by Prelog (2006) discussed about the 
effects of aging as a risk factor for autoimmunity.  Immunosenescence (aging of the 
immune system) is characterized by changes in T cell subsets, cellular and molecular level 
alterations and thymus atrophy, resulting in the decline of B and T cell function.  It has 
been hypothesized that involution of the thymus resulting in a decline of naïve T cells and 
the accumulation of memory T cells, activated by neoantigens, may contribute to the 
development of autoimmune diseases (Prelog, 2006).   
 
1.2 Type 1 diabetes  
1.2.1 Introduction   
There are two major types of diabetes, Type 1 diabetes, formerly known as Insulin 
Dependent Diabetes Mellitus (IDDM) and Type 2 diabetes, also formerly known as Non-
insulin Dependent Diabetes Mellitus (NIDDM).  Type 2 diabetes occurs primarily due to 
insulin resistance and secretion disorder.  As a result, higher levels of insulin are needed for 
cells to uptake and metabolize glucose (Ekoe & Zimmet, 2001b).  Disorders in Type 2 
diabetes could be caused by environmental factors like diet, sedentary lifestyle and genetic 
factors like gene mutations that impair insulin receptors.  Type 2 diabetes is the most 
common class among patients.  Usually, they are treated with drugs that sensitize cells to 
insulin action or inhibition of gluconeogenesis (Hundal et al., 2000; Mayerson et al., 2002) 
and control of glucose intake in diet. 
Type 1 diabetes is an organ specific autoimmune disease affecting the pancreas.  
Over a period of time, cells of the immune system would infiltrate the pancreas, invade the 
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islet of Langerhans (insulitis) and selectively destroy the β-islet cells that produce insulin.  
The autoimmune process is silent over months to several years, until the number of β-islet 
cells are no longer sufficient to maintain normal glucose homeostasis (Ekoe & Zimmet, 
2001b; Cnop et al., 2005; Seissler & Scherbaum, 2006).  The low level of insulin would 
lead to hyperglycemia and cause long-term complications and dysfunction of several 
organs and tissues.  Insulin injections are needed for lifetime treatment. 
Most of the studies on Type 1 diabetes were carried out on animal models like the 
Bio Breeding (BB) Rat, non-obese diabetic (NOD) mice and transgenic mice due to the 
small number of human patients available and access are only from blood samples (Bach, 
1997).   
 
1.2.2 The importance of T cells in the pathogenesis of Type 1 diabetes 
The autoimmune process of Type 1 diabetes is dependent on CD4+ and CD8+ T 
cells.  Type 1 diabetes is thought to be mediated and propagated by the effects of pro-
inflammatory and Th1 cytokines secreted by CD4+ T cells, which induces inflammation 
and recruits other cell types that are the final effectors of β-islet cell destruction 
(Rabinovitch & Suarez-Pinzon, 1998; Raz et al., 2005).  NOD mice were observed to have 
an age progressive accumulation of CD4+ T cells expressing the Th1 cytokine profile in the 
infiltrated pancreas of Type 1 diabetes (Gregori et al., 2003).  The study by Gregori et al. 
(2003) also observed that the progression of diabetes in NOD mice depends on reduced 
activity of a suppressive CD4+ T cell subset called regulatory T cells (CD4+, CD25+) and 
increased pathogenecity of effector T cells (CD4+, CD25-).  Compared to young NOD mice 
(8 weeks), regulatory T cells isolated from old NOD mice (16 weeks) did not efficiently 
inhibit the development of induced Type 1 diabetes in Severe Combined Immune Deficient 
(SCID) NOD mice when injected together with splenocytes from pre-diabetic and diabetic 
NOD mice.  In in-vitro studies, effector T cells from old NOD mice were also less 
susceptible to regulation by regulatory T cells when stimulated with alloantigens.  
Therefore, development of autoimmune diabetes depends on the dynamic interaction 
between effector and regulatory T cells (Gregori et al., 2003).  On the genetic side, an 
association has been observed between polymorphism of the CD4 gene promoter in T cells 
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with Type 1 diabetes.  Mutation studies had identified 3 frequently occurring single 
nucleotide polymorphisms (SNPs) in Danish parents with Type 1 diabetes offspring.  
Further studies of the SNPs identified four frequent haplotypes with the A4TGC haplotype 
producing higher promoter activity in reporter assays.  This haplotype in the CD4 promoter 
confers risk of Type 1 diabetes by increasing CD4 surface expression, leading to more 
efficient activation of autoreactive T cells and eventually β-islet cell destruction 
(Kristiansen et al., 2004).                                                                                                                                  
The role of CD8+ T cells in the pathogenesis of Type 1 diabetes is quite 
controversial.  Early studies of transplanting splenic T cells from diabetic to irradiated 
NOD mice show the synergistic requirements of CD4+ and CD8+ T cells to cause diabetes 
(Christianson et al., 1993; Nagata et al., 1994).  But Wong et al. (1996) had isolated 
diabetogenic CD8+ T cell clones that are capable of causing diabetes in irradiated NOD 
mice without the help of CD4+ T cells.  The ability of CD8+ T cells to cause diabetes is 
donor age dependent.  The isolated cells were believed to represent a population involved 
in the early phases of the disease (Wong & Janeway, 1999a).  CD8+ T cells were required 
for a pathogenic response to islet cells, but once CD4+ T cell response develops, CD8+ T 
cells are not necessarily needed to cause diabetes (Haskins & Wegmann, 1996).  Graser et 
al. (2000) created transgenic NOD mice that express TCR genes from autoreactive CD8+ T 
cells isolated from invaded pancreatic islets of normal NOD mice.  The transgenic mice 
were observed to have a high rate of diabetes development.  Even when induced with 
mutations that eliminated CD4+ T cells, diabetes development still occurs at an accelerated 
rate.  However, the frequency of CD8+ T cell clones that can independently cause Type 1 
diabetes is lower in normal NOD mice compared to the transgenic mice.  Thus, most of the 
CD8+ T cell clones that contribute to the development of Type 1 diabetes require the helper 
functions of CD4+ T cells.  But there is variability in the helper function of CD4+ with 
CD8+ T cells in contributing to the development of Type 1 diabetes (Graser et al., 2000).     
 Contemporary studies mainly focus on the role and importance of regulatory T cells 
(Aoki et al., 2005).  Regulatory T cells are important controllers of autoimmunity by 
suppressing the expansion of autoimmune effecter T cells.  The expression of a gene called 
Foxp3 is required for the generation and activity of those cells and mice with Foxp3 
knockout genes have a deficit of regulatory T cells (Chen et al., 2005).  The importance of 
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regulatory T cells in suppressing Type 1 diabetes had been proven in many experiments 
(Green et al., 2002; Tang et al., 2004; Herman et al., 2004; Tarbell et al., 2004; Jaeckel et 
al., 2005; Chen et al., 2005).  However, the mechanism of suppression is still subject to 
further studies.  A microarray analysis by Chen et al. (2005) observed that regulatory T 
cells isolated from the insulitic lesion of diabetic NOD mice had a different gene 
expression profile compared to regulatory T cells isolated from the mesenteric and 
pancreatic lymph nodes.  Among the genes that were differently expressed were IL-10, 
CD103, S100a67 and chemokine receptors like CCR5, CXCR3, CCR2 and CCR6.  The 
anti-inflammatory gene expression profile seems to be amplified in regulatory T cells 
isolated from the insulitic lesion.  The study by Herman et al. (2004) observed that 
regulatory T cells also had a significantly higher expression of IL-10 in addition to 
inducible co-stimulator (ICOS) gene.  Blockade of ICOS action by antibody treatment leads 
to rapid diabetes at the onset of insulitis.  In the cell signaling aspect, the generation of 
regulatory T cells was dependent on the signaling between TNF-related activation induced 
cytokine (TRANCE) protein in T cells and receptor activator of NF-κB (RANK) in APC.  
Blockade of TRANCE-RANK signaling causes a decrease in the number of regulatory T 
cells in the pancreatic tissue, resulting in the generation of autoreactive CD8+ T cells in 
young mice and progression to diabetes (Green et al., 2002).   
 
1.2.3 The importance of other cell types in the pathogenesis of Type 1 diabetes 
The pathogenesis of Type 1 diabetes does not solely rely on T cells, as there were 
also other cells present during insulitis.  The other cells that play a role in the pathogenesis 
of Type 1 diabetes include APC like macrophages, natural killer T (NKT) cells, dendritic 
cells (DC) and B-lymphocytes (Kukreja & McLaren, 1999).  Macrophages had been 
identified to produce inflammatory cytokines and free radicals that are toxic to β-islet cells.  
The role of macrophages and its chemical secretions had been determined to be important 
in the promotion of the Th1 immune response and the differentiation of cytotoxic β-islet T 
cells.  In NOD mice treated with liposomal dichloromethylene diphosphate (LipCl2MDP) 
(selectively toxic to macrophages), there was a decrease in the production of macrophage 
derived IL-12 and a shift of the immune balance to the Th2 phenotype, which prevented the 
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destruction of β-islet cells (Jun et al., 1999).  However, the T cells in LipCl2MDP treated 
NOD mice did not lose their ability to develop into β- islet cytotoxic cells.  Established T 
cells were able to recover their function as soon as being transplanted into new SCID NOD 
mice with intact macrophages (Jun et al., 1999).  
The presence of NKT cells have been observed to play an important role in the 
prevention of Type 1 diabetes and these cells are deficient in NOD mice (Godfrey et al., 
1997).  NKT cells are lymphocytes that express both the surface markers of T (such as α/β-
TCR) and NK (such as NK1.1, CD16 and Ly49A) cells.  The research by Hammond et al. 
(1998) isolated a subset of cells from the thymus of congenic NOD mice (α/β-TCR+CD4-
CD8-) that is enriched with NKT cells.  When injected into young female NOD mice, 
substantial resistance to development of Type 1 diabetes was observed compared to mice 
injected with whole thymocytes and PBS buffer.  The cell subset was also injected together 
with splenocytes from diabetic NOD mice to determine its effects on the induction of Type 
1 diabetes in irradiated adult NOD mice.  The results show significant resistance towards 
Type 1 diabetes development compared to irradiated NOD mice receiving splenocytes 
alone, even when the number of cells in the subset was reduced.  When the mice were 
treated with antibodies against IL-4 and IL-10, there was an increase of Type 1 diabetes 
development.  By this, the researchers propose that the deficiency of NKT cells in NOD 
mice contributes to the pathogenesis of Type 1 diabetes by permitting a disproportionate 
Th1 response to emerge (Hammond et al., 1998).  A similar study by another research 
group also observed the prevention of Type 1 diabetes in SCID NOD mice injected with 
CD1d-restricted non-classical NKT cells and splenocytes from diabetic NOD mice (Duarte 
et al., 2004).  An elucidating study has observed that activated NKT cells provided diabetes 
protection by promoting the migration and maturation of DC in pancreatic lymph nodes, 
where they suppress autoreactive T cells (Chen et al., 2005).     
DC had been identified to play an important role in the expansion of regulatory T 
cells that prevents the onset of diabetes by suppressing autoreactive T cells.  The study by 
Tarbell et al. (2004) used DC and a β-islet cell mimetope (BDC peptide) as the antigen to 
activate and proliferate regulatory T cells in-vitro.  The generated cells were observed to 
suppress the proliferation of non-regulatory T cells in-vitro and the pathogenesis of Type 1 
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diabetes in-vivo.  In diabetes induction experiment, when the number of DC proliferated-
regulatory T cells transplanted into SCID NOD mice were decreased until a certain 
threshold and autoreactive splenocytes from normal diabetic NOD mice were increased, 
there was still significant inhibition of Type 1 diabetes development.  Therefore, 
autoantigen-specific, DC expanded regulatory T cells functions efficiently in-vivo to 
suppress Type 1 diabetes mediated by autoreactive T cells (Tarbell et al., 2004).    
The role of B cells in Type 1 diabetes however is poorly defined.  The study by 
Carillo et al. (2005) had detected autoantibodies secreted specifically against the pancreatic 
nervous system in most of the hybridoma cell lines generated from islet infiltrating B cells 
of diabetic NOD mice.  On the other hand, Wong et al. (2004) observed that the antigen 
presenting properties of B cells seem to play a more important role in the pathogenesis of 
Type 1 diabetes compared to autoantibody secretion.  They generated a transgenic mouse 
that produces B cells with antigen presenting capability but could not secrete antibodies.  
They observed that the transgenic mice had a significantly higher incidence of developing 
Type 1 diabetes compared to the negative control strain that secretes antibodies (Wong et 
al., 2004).  Investigative studies had proposed that defects in the MHC gene expression of 
B cells could contribute to the pathogenesis of Type 1 diabetes (Noorchasm et al., 1999; 
Hussain & Delovitch, 2005).  
  
1.3 Epidemiology of Type 1 Diabetes 
1.3.1 Diagnosis and etiology 
The most important factor and hallmark for diagnosing diabetes mellitus is 
hyperglycemia (Graves & Eisenbarth, 1999).  Studies in populations with high prevalence 
of diabetes show that normal blood glucose values are bimodally distributed with a cut off 
point of 11.1 mmol/l (Ekoe & Zimmet, 2001a).  This observation also agrees with the 
results of a study on Malaysians, which has a low prevalence of the disease (Lim et al., 
2002).  The World Health Organization (WHO) recommends a fasting plasma glucose 
value of more than 7.0 mmol/l as an indicator for diabetes mellitus (Ekoe & Zimmet (b), 
2001).  The net effects of genetics, environmental factors and immune dysregulation 
influence the development of this disease (Skyler et al., 2001, Gorodezky et al., 2006; 
Seissler & Scherbaum, 2006).   
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On the genetic side, the HLA class II region has been found to play an important 
role in the susceptibility of this disease.  It contributes 50% of the inherited risk for Type 1 
diabetes (Gorodezky et al., 2006).  The HLA class II allele DQ2, DQ8, DR3 and DR4 have 
been known to confer susceptibility to diabetes.  In contrast, HLA DQ6 confers resistance 
to the disease (Graves & Eisenbarth, 1999; Skyler et al., 2001).  The role of genetics in 
Type 1 diabetes is further demonstrated in inheritance of the disease and a high 
concordance rate for Type 1 diabetes in monozygotic twins (35-50%) than in dizygotic 
twins (5-10%).  However, there are other indicators that suggest an environmental factor 
like the other 65-50% discordance rate of diabetes in monozygotic twins.  There is also a 
seasonal variation in the disease onset where peak incidences are observed at certain times 
of the year (Graves & Eisenbarth, 1999; Green & Kyvik, 2001; Skyler et al., 2001).  Other 
environmental factors have been suggested and reviewed that includes viral infection 
(Rubella and Coxsackie B), neonatal nutrition (cow’s milk), chemical toxins (nitrosamine), 
stress and sex hormones (Bach, 1997; Graves & Eisenbarth, 1999; Skyler et al., 2001). 
 
1.3.2 Disease distribution 
Type 1 diabetes is a disease with variable geographic and ethnic distribution.  The 
highest worldwide prevalence occurs in Finland and Sardinia and the lowest prevalence 
appears in orientals (Gorodezky et al., 2006).  It is prevalent among the Caucasian race, 
particularly in Northern Europe, compared to populations in Asia and South America.  
However, significant increases were also detected among Asians in China and Japan, 
Mestizos in Peru and Polynesians in Hawaii.  The number of patients with Type 1 diabetes 
is increasing worldwide (about 3% per year) in both low and high incidence populations 
(Onkamo et al., 1999).   
In Singapore, a study conducted by Lee et al. (1998) also showed that although the 
incidence of Type 1 diabetes was rare, the number of patients were increasing, being 1.4 
per 100000 children in 1992, 2.4 per 100000 in 1993 and 3.8 per 100000 in 1994.  The age-
standardized incidence rate of Type 1 diabetes was 2.46 per 100000 in 0 – 12 year-old 
children.  There was a preponderance of this disease to females (male to female ratio is 
1:1.85) and this was quite similar when compared to other Asian populations like Thailand 
and Hong Kong.  This was in contrast to Western populations where the incidence of 
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disease was equal between both sexes.  The age group that had the highest incidence was 
10-12 years old and the overall average age for the onset of Type 1 diabetes in boys and 
girls were 5.6 and 7 years respectively.   
It was also observed that the frequency of Type 1 diabetes varies according to the 
ethnic group in a same geographic area.  In the USA, Hispanics and African Americans had 
a lower prevalence than Caucasians.  In China, a low risk country, the Zhuang ethnic had a 
lower prevalence than the Mongols (Gorodezky et al., 2006).  In South East Asia, data from 
Singapore shows that the Indian population had a higher risk with an incidence of 5.78 per 
100,000 children, followed by Chinese (2.25/100,000) and Malays (1.23/100,000) (Lee et 
al., 1998).  However, the data had to be interpreted carefully due to the small number of 
patients.  The incidence of Type 1 diabetes among the Chinese in Singapore, who were 
mainly of Southern Chinese descend, was similar to that of Hong Kong and Japan.  When 
compared among other Asian countries, the overall incidence in Singapore is slightly 
higher among countries with oriental races but still far lesser than Caucasian countries.    
 
Table 1.1 Compiled data of Type 1 diabetes incidence in several countries with 
different populations (Lee et al., 1998; Onkamo et al., 1999) 
Country Incidence per 105 Age group 
Hong Kong 1.7 < 15 years 
Japan 1.65-2.0  < 15 years 
Korea 0.6  < 15 years 
Shanghai 0.72 < 15 years 
Australia 11-22 < 15 years 
Finland 30.3 < 15 years 
France 8.0 < 15 years 
Sweden 24.9 < 15 years 
Singapore 2.46 < 12 years 
Singapore Chinese 2.25 < 12 years 
Singapore Malay 1.23  < 12 years 
Singapore Indian 5.78 < 12 years 
 
The data on Type 1 diabetes in Malaysia is quite limited.   Malaysia is a low disease 
prevalence country with an incidence of 0.3 per 100000 persons aged less than 16 years 
(Tan et al., 2005).  In a study on glycemic control of diabetic patients, Ismail et al. (2000) 
compiled some data on the number of Type 1 and 2 diabetic patients from hospitals around 
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peninsular Malaysia.  Out of 926 patients, 329 had Type 1 diabetes.  Ethnic distribution of 
patients varies between hospitals.  When compiled according to ethnicity, the patients had a 
mean age of onset at 17.5 – 18.9 years.  In a study of blood glucose levels conducted by 
Lim et al. (2002), a total of 19218 subjects were recruited all over East and West Malaysia.  
In the sample, it was observed that the prevalence of diabetes (Type 1 and 2) is equal 
among males and females (7.0 and 7.1 % respectively).  Indians had a higher percentage of 
diabetes prevalence compared to Malays, Chinese and other indigenous ethnics.  
Unfortunately, the study did not specifically focus on Type 1 diabetes and most of the 
diabetic subjects were of the Type 2 group.   
 
1.3.3 Complications and mortality 
Type 1 and 2 diabetes may present with the characteristic symptoms of thirst, 
polyuria, polydypsia, blur vision, weight loss and infections.  In the most severe form, 
ketoacidosis may develop, leading to coma and death.  Long-term complications include 
nephropathy (causing renal failure), retinopathy (with potential blindness) and neuropathy 
with risk of foot ulcers, amputation, charcot joints and autonomic dysfunction (Ekoe & 
Zimmet, 2001a).  Diabetic individuals are also at higher risk of cardiovascular, peripheral 
vascular and cerebrovascular disease.  In Singapore, the most common cause of death from 
diabetic complications is ischaemic heart disease (mainly Malays and Indians), 
cerebrovascular disease, chronic renal failure (mainly Chinese), infections (mainly 
respiratory tract infections) and diabetic ketoacidosis (mainly Type 1 Diabetic patients) 
(Cutter, 1998).  Type 1 and 2 diabetes was the sixth most important cause of death and third 
most common reason for attendence in government outpatient clinics (Lee, 2000).   
Good glycemic (blood glucose level) control can prevent the development of 
diabetic complications.  In Malaysia, a study was done by Ismail et al. (2000) to determine 
the factors that affect glycemic control in Malaysia.  Generally, overall glycemic control 
was poor among Malaysian patients.  The authors identified 3 factors that affect glycemic 
control in Type 1 and 2 diabetes.  They were availability of nurse educators, ethnicity and 
the waist to hip ratio (WHR) of patients.  In the study, hospitals that lack educator nurses 
had the highest number of patients with poor glycemic control.  The study also observed 
that the Chinese had better glycemic control compared to Indians and Malays, partially 
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because of protective genes and lifestyle.  Intra-abdominal fat is associated with insulin 
resistance and therefore, patients with high WHR usually have poor glycemic control.  In 
terms of socioeconomic status, household income was an important determinant of 
glycemic control in Type 1 diabetes due to the cost of disease treatment.  Educational 
background does not influence the glycemic control of Malaysian diabetics.  Data from a 
later study by Tan et al. (2005) on the association between ethinicity, depression and 
quality of life with glycemic control of Type 1 diabetes patients also concurs with the 
results of the study by Ismail et al. (2000).  In addition, the study also observed that good 
diabetes control is associated with good functional families, which brings a better quality of 
life.    
 
1.4 Cytokines 
1.4.1 The role of cytokines 
The chemical balance in Th1 and Th2 immune response is important in the 
development of Type 1 diabetes.  While the Th1 immune response promotes cell-mediated 
immunity that may damage tissue, the Th2 immune response provides help for B-
lymphocytes in the production of antibodies, particularly IgG1 and IgE in the mouse 
(Wong & Janeway, 1999a).  Examples of pro-inflammatory and Th1 cytokines are 
interleukins (IL-1, IL-2 & IL-12), Tumour Necrosis Factors (TNF-α & TNF-β) and 
Interferon’s (IFN-α & IFN-γ) (Kukreja & MacLaren, 1999).  In Type 1 diabetes, most of 
the pancreas infiltrating T cells secretes cytokines of the Th1 group (Trembleau et al., 
2003).  The study by Lejon & Fathman (1999) isolated an antigen reactive CD4+ T cell that 
had a high expression of the CD4 molecule from invaded β-islets of diabetic NOD mice.  
The cells were observed to be very potent in transferring diabetes and had a Th1 cytokine 
profile with reduction in IL-4 expression.  Since the inflammatory process of Type 1 
diabetes was mediated by the effects of pro-inflammatory and Th1 cytokines, it was 
hypothesized that skewing the cytokine cascade from a Th1 to a Th2 profile could prevent 
the disease (Raz et al., 2005).  Experimental manipulations like the administration of 
Complete Freund’s Adjuvant (CFA) and Bacillus Calmette – Guerin (BCG) in NOD mice 
can divert the destructive pathway of β-islet cells to a non-destructive pathway due to the 
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increase of Th2 cytokines like IL-4 and IL-10 (Calcinaro et al., 1997; Tominaga et al., 
1998; Serreze et al., 2001; Lee et al., 2003).   
Chemicals secreted by immune cells that promote the Th1 phenotype immune 
response and inflammation were well known to damage β-islet cells that produce insulin 
and cause Type 1 diabetes (Pilstrom et al., 1997; Rabinovitch & Suarez-Pinzon, 1998; 
Yadav & Sarvetnick, 2003; Cnop et al., 2005).  It also prevents the replication and 
regeneration of new β-islets and this reduces the number of insulin producing cells in the 
pancreas (Meier et al., 2006).  In a study of immune cell infiltration, cytokine expression 
and β-islet apoptosis in the diabetic rat model (Lew.1AR1/Ztm-iddm), it was observed that 
the expression of IL-1β and TNF-α by immune cells increased progressively with islet 
infiltration, leading to the destruction of β-islets (Jorns et al., 2005).  In in-vitro studies, a 
combination of IL-1β, TNF-α and IFN-γ shows enhanced damage to cultures of β-islet 
cells of diabetes prone and resistant BB Rats (Wachlin et al., 2003).  In a dose dependent 
manner, it also decreases the population and replication rate whilst increasing the apoptotic 
frequency of cultured rat insulinoma and human β-islet cells (Meir et al., 2006).  IFN-γ is 
known to increase the expression of MHC I and II genes, which allows better recognition 
of the peptide antigens presented by these molecules (Wong & Janeway, 1999a).  The up-
regulation of MHC I genes might render β-islet cells susceptible to CD8+ T cell mediated 
destruction.   
IL-12 is mainly produced by activated APC like macrophages and plays a pivotal 
role in the differentiation and expansion of the Th1 arm of the immune response, which in 
turn, is required for eliciting organ specific autoimmunity.  Besides having an effect on the 
development of CD4+ Th1 cells, IL-12 is also required for the generation of CD8+ T cells 
from naïve T cells (Yadav & Sarvetnick, 2003).  In the study by Trembleau et al. (2003), 
IL-12 administration induces the secretion of IFN-γ and accelerates the development of 
Type 1 diabetes in NOD mice.  It also accelerates the development of Type 1 diabetes in 
NOD mice with knockout IFN-γ genes, dispensing the role of IFN-γ.  In that experiment, 
the dual role of IFN-γ (pathogenic and protective) was observed.  The pathogenic role of 
IFN-γ was due to the increased production of nitric oxide (NO) by an enzyme called 
inducible nitric oxide synthase (iNOS).  NO is a toxic mediator that destroys β-islet cells 
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and the production of NO is dependent on IFN-γ secretion.  On the other hand, the 
protective role is mainly caused by the increased apoptotic frequency of CD4+ T cells due 
to high IFN-γ levels induced by IL-12, which inhibits the development of Type 1 diabetes 
(Trembleau et al., 2003).           
Besides IL-12, macrophages also produce IL-15 and IL-18, which are mediators of 
innate immunity.  Both IL-15 and IL-18 play a pivotal role in the pathogenesis of chronic 
inflammatory autoimmune diseases such as collagen-induced arthritis.  In experiments 
where diabetes was induced using streptozotocin, mice treated with soluble murine IL-15 
receptor α-chain had a significantly reduced glycemic level compared to controls.  It was 
also observed that IL-18 knockout mice were significantly more resistant to diabetes 
induced by streptozotocin and do not develop typical islet infiltration (Lukic et al., 2003).  
IL-15 acts as a growth factor and an activator of CD8+ memory T cells whereas IL-18 acts 
synergistically with IL-12 to increase the production of IFN-γ by Th1 cells (Lukic et al., 
2003).  Figure 1.1 shows a proposed scheme on the effects and mechanisms of immune 
cells and cytokines in β-islet cell destruction.      
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Figure 1.1 Pathogenesis of Type 1 Diabetes (Rabinovitch and Suarez-Pinzon, 1998) 
A proposed scheme of immune cells and cytokines that are involved in the autoimmune destruction of β-islet 
cells.  Antigen in the β-islet cells activate APC which in turn activate CD4+ T cells, predominantly of the Th1 
subset.  β-islet cells are destroyed by two mechanisms, that is cell lysis through interaction with cytotoxic 
macrophages, CD8+ T cells and non-specific inflammatory mediators like free radicals and cytokines.   
 
1.4.2 Mediators of cytokine induced β-islet cell destruction 
Cytokines can cause cellular dysfunction like decrease in islet insulin content, 
suppression of glucose stimulated insulin secretion, generation of enhanced amounts of 
NO, damages to cell membranes (Wachlin et al., 2003), induction of DNA strand breaks 
and apoptosis (Delaney et al., 1997; Cnop et al., 2005).  Hence, pioneering research on the 
mechanism of cytokine induced β-islet cell destruction in Type 1 diabetes mainly focused 
on damaging mediators like oxygen and nitrogen free radicals.  Cytokines like IL-1, TNF-α 
and IFN-γ had been observed to induce the formation of superoxide, NO and peroxynitrite 
in β-islet cells, which is auto-destructive (Rabinovitch & Suarez-Pinzon, 1998).  NO is 
mainly produced by iNOS, which catalyzes L-arginine to Nω-hydroxy-L-arginine and 
finally to form L-citruline and NO using NADPH as a reducing agent (Beshay et al., 2001; 
Pagliaro, 2003).  Peroxynitrite, a product formed by the combination of NO and superoxide 
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free radicals, is a very potent oxidant and cytotoxic mediator that has been shown to cause 
necrosis in cultured human and rat β-islet cells (Delaney el al., 1997).  It has also been 
identified to irreversibly inhibit respiration in the mitochondria, which leads to cellular 
damage (Pagliaro, 2003).   
Cytokine induced peroxynitrite formation in cultured human β-islet cells were 
observed to be dependent upon the increase of superoxide generation, and is independent of 
NO production, although it increases the level of NO.  This was supported by the 
destruction of cultured β-islet cells that were treated with L-NG-monomethyl arginine 
(NMA), an inhibitor of iNOS that reduces the production of NO.  On the other hand, 
destruction of cultured β-islet cells was prevented by the addition of a peroxynitrite 
scavenger and superoxide inhibitor, guanidinoethyl disulphide (GED) (Lakey et al., 2001).  
In in-vivo studies, GED was observed to delay the onset and significantly reduce the 
incidence of Type 1 diabetes in female NOD mice (Suarez-Pinzon et al., 2001).   
However, the role of NO could not be ignored in cytokine induced cell destruction, 
as it was still needed for the production of peroxynitrite and the regulation of certain genes.  
It is also produced by β-islet cells and can induce damage in response to cytokines (Thomas 
et al., 2002).  In a clinical setting, the study by Hoeldtke et al. (2003) observed that there 
was a significant conversion of NO to peroxynitrite in the blood plasma of Type 1 diabetes 
patients.  Peroxynitrite has been observed to cause endothelial dysfunction, 
vasoconstriction and dysfuntional vasopressor responses in human diabetes.   
 
1.4.3 Gene regulation and signaling pathways of β-islet cell destruction 
Contemporary research has mainly focused on the molecular mechanism of gene 
regulation and cell signaling.  Microarray technology has allowed detailed observations of 
genome expression in a pathogenic event.  This technology has been used to observe the 
gene expression of cultured β-islet cells exposed to cytokines and its dependence on NO to 
apoptotic destruction.  In the study by Kutlu et al. (2003), insulin producing INS-1E cells 
were cultured and exposed to IFN-γ, IL-1β and with or without NMA at 6 different time 
intervals.  In the microarray analysis, a total of 698 genes were affected by cytokines at one 
time point.  Although cytokine induced apoptosis of INS-1E cells were independent of NO 
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production, 50% of the genes affected by cytokines were also affected by NO production 
after 6-8 hours of culture (based on the influence of NMA on gene expression), suggesting 
a role for NO in the late effects of cytokine induced cell destruction.  During NO 
production, besides the up regulation of iNOS and AS (the enzyme that recycles citrulline 
into arginine, allowing continuous NO production), a new gene, guanosine triphosphate 
cyclohydrolase I (GTPCH), was also identified to be up regulated.  GTPCH is involved in 
the production of tetrahydrobiopterin, which is a cofactor for the iNOS enzyme.  When the 
genes were clustered according to their functions, genes involved in metabolism was 
observed to be the most affected by cytokines, especially lipid metabolism with more than 
half of the genes were NO dependent.  Other major affected clusters include cytokine 
processing and signal transduction genes and transcription factors.  Cytokines also 
decreased the expression of genes related to differentiate β-islet cell functions and 
preservation of cell mass like Pdx-1, Isi-1, insulin, GLUT2 and glucokinase.  It also up 
regulates pro-apoptotic genes like Bid and Bak (Kutlu et al., 2003).  The network of genes 
affected by the combination of IL-1β and IFN-γ are summarized in Figure 1.2.   
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Figure 1.2 The network of genes up regulated (up arrow) and down regulated  
(down arrow) by IL-1β and IFN-γ that contributes to the apoptosis of β-
islet cells (Cnop et al., 2005)  
Cluster of genes regulated by IL-1β and IFN-γ compiled from multiple microarray references (including 
Kutlu et al.) in the review by Cnop et al. (2005).  The transcription factors NF-κB and STAT-1 seems to be 
the main regulator of gene expression that leads to β-islet cell death.  
 
Cytokines could induce cell damage through many signaling pathways like 
JAK/STAT (Cnop et al., 2005), JNK/SAPK (Kim et al., 2005) and FRK/RAK (Welsh et 
al., 2004).  The activation of tyrosine kinase JAK by IFN-γ would cause the 
phosphorylation of STAT-1, which potentiates the effects of iNOS expression.  Excessive 
activation of the JAK/STAT signaling may lead to cell death and is regulated by negative 
feedback mechanisms such as the up regulation of the Suppressor Of Cytokine Signaling 
(SOCS) gene.  SOCS-3 had been observed to prevent cytokine induced islet cell death by 
reducing the level of NO and inhibiting the activity of STAT-1 (Karlsen et al., 2001).   
Activation of the JNK/SAPK signaling by TNF-α and IFN-γ in cultures of isolated 
mice pancreatic β-islet cells and insulinoma cell line (MIN6N8) resulted in apoptosis that 
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correlates with the translocation of Bax into the mitochondria, the release of cytochrome c 
and the activation of caspase-3.  JNK/SAPK signaling also induces the expression of p53 
and p21 protein, which correlates with the loss of mitochondria membrane potential and 
production of reactive oxygen species that finally leads to apoptosis.  Apoptosis and the 
expression of p53 protein were prevented when the cell cultures were treated with 
SP600125, a specific JNK inhibitor (Kim et al., 2005).  The FRK/RAK signaling pathway 
had also been observed to increase the susceptibility of β-islet cells to cytokine induced cell 
death.  β-islet cells isolated from FRK/RAK knockout mice pancreas were observed to be 
more resistant to cell death when cultured with IL-1β and IFN-γ compared to normal mice.  
In normal β-islet cells treated with inhibitors or transfected with small interfering RNA 
(siRNA) to interfere with FRK/RAK expression, cytokine induced cell death was also 
significantly reduced (Welsh et al, 2004).  The review by Cnop et al. (2005) proposed a 
few mechanisms of cytokine induced gene expression and signaling patterns that result in 
β-islet cell death as shown in Figure 1.3. 
 
 
 
Figure 1.3 Proposed mechanism of gene expression and signaling pathways leading 
to cytokine induced cell death (Cnop et al., 2005) 
β-islet cell apoptosis is mediated by three pathways that includes activation of stress proteins like JNK, p38 
MAPK, ERK and NF-κB.  This triggers reticulum endoplasmic stress and the release of death signals from 
the mitochondria. 
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1.5 Peroxisome Proliferator-Activated Receptor (PPAR) 
1.5.1 Introduction and structural functions 
The peroxisome proliferator-activated receptor (PPAR) is a transcription factor that 
belongs to the nuclear hormone receptor superfamily.  PPAR is mainly involved in cellular 
energy usage and adipogenesis by regulating a broad range of genes involved in glucose 
and lipid metabolism and adipocyte differentiation.  Currently, there are 3 known subtypes 
of PPAR, that is PPAR-α, PPAR-δ/β and PPAR-γ.  Each subtype of PPAR has a different 
tissue distribution, is very similar in molecular structure and is encoded by different genes 
mapped to human chromosomes 22, 6 and 3 respectively (Bar-Tana, 2001; Rotondo & 
Davidson, 2002).  In the mouse, PPAR-α, PPAR-δ/β and PPAR-γ is located in 
chromosomes 15, 17 and 6 respectively (Yousef & Badr, 2004).  The PPAR protein 
consists of 5 domains: a ligand independent transactivation domain (Domain A/B), a DNA 
binding domain (Domain C), a hinge region (Domain D) and a ligand-binding domain 
(Domain E/F) as shown in Figure 1.4 (Kota et al., 2005). 
The ligand independent transactivation domain (Domain A/B) is a domain that 
contains the Activation Function 1 (AF1), which is transcriptionally active in the absence 
of ligands.  The DNA binding domain (Domain C) is highly conserved in all the isoforms, 
supporting the fact that all three PPAR isoforms bind to the same DNA response element, 
the PPAR Response Element (PPRE).  PPRE consist of a direct repeat of the 
hexanucleotide DNA sequence AGGTCA separated by one or two nucleotides, termed 
Direct Repeat 1 and 2 (DR1 & DR2).  The hinge region (Domain D) is the docking site for 
co-factors.  The ligand binding domain (Domain E/F) is less conserved, allowing each 
subtype to have its own activating ligand.  The domain consists of 12 α-helical regions 
named H1 to H12 and are also a binding site for co-activator proteins (Zhang & Young, 
2002; Kota et al., 2005; Lazar, 2005).  The ligand binding domain also contains the 
Activating Function 2, which mediates conformational changes through a conserved 
hydrogen-bonding network to create an interacting surface with co-activator proteins upon 
binding with a ligand (Cronet et al., 2001; Blanquart et al., 2003).   
Natural ligands for PPARs are mostly fatty acids and their derivatives.  The 
eicosanoid derivatives from the lipoxygenase pathway such as Leukotriene B4 (LTB4) and 
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oxidized phospholipids are natural ligands for PPAR-α.  The natural activating ligands for 
PPAR-γ are prostaglandins like 15-deoxy-Prostaglandin J2 (15d-PGJ2), a product of 
arachidonic acid metabolism and hexadecyl azeloayl phosphatidylcholine (azPC), a product 
of oxidized low-density lipoproteins (Zhang & Young, 2002).  Synthetic ligands include 
lipid-lowering fibrates for PPAR-α and thiazolidinediones, a class of drugs termed 
glitazones (insulin sensitizers for the treatment of Type 2 Diabetes) for PPAR-γ.   
 
 
Figure 1.4 The linear structure of PPAR (Kota et al., 2005) 
The PPAR protein consists of 5 domains, a ligand independent transactivation domain (Domain A/B), a DNA 
binding domain (Domain C), a hinge region (Domain D) and a ligand-binding domain (Domain E).  Domain 
A/B is an activating domain that is ligand independent.  Domain C is implicated in DNA binding of target 
gene.  Domain D is a binding region for co-factors and Domain E/F is also an activating domain but is ligand 
dependent.   
 
1.5.2 Activation and transcriptional control 
In an inactive state, PPARs are bound with a nuclear co-repressor (NCo-R) 
containing histone deacetylase activity, which inhibits transcriptional activities (Kota et al., 
2005).  Upon binding with a ligand, the NCo-R is released and the free PPAR would form a 
heterodimer with another nuclear receptor protein, the Retinoid X Receptor (RXR) (Zhang 
& Young, 2002).  The PPAR:RXR heterodimer would be translocated into the nucleus and 
bind to the PPRE located in the promoter of target genes (Moraes et al., 2006).  Activated 
PPARs could also recruit accessory proteins like Nuclear Co-Activators (NCo-As), Cyclic-
AMP Response Element Binding Protein/P300 (CBP/p300) and CCAAT/Enhancer binding 
proteins (C/EBP) (Rosen et al., 2002) that are essential for the initiation of gene 
transcription.      
Besides natural and synthetic activating ligands, the transcriptional activities of 
PPARs are also regulated by post-translation mechanisms including phosphorylation and 
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ubiquination.  The activities of PPARs are activated or deactivated following 
phosphorylation by the Mitogen Activated Protein Kinase (MAPK) or Protein Kinase A 
(PKA) signaling pathway as shown in Figure 1.5.  The phosphorylation of PPAR-α is 
increased in response to insulin through the MAPK pathway and this correlates with the 
enhancement of transcriptional activity (Shalev et al., 1996; Blanquart et al., 2003).  
PPAR-γ is also a phosphoprotein, which however, differs with PPAR-α, in that 
phosphorylation inhibits its transcriptional activities (adipogenesis) in mice and rat 
fibroblast (Hu et al., 1996).   
 
 
 
Figure 1.5 Kinase pathways implicated in the phosphorylation and in the 
regulation of ligand independent PPAR transcriptional activity 
(Blanquart et al., 2003) 
Kinase signaling is one of the ligand independent activation mechanisms of PPAR proteins.  MAP Kinase 
phosphorylation increases the activity of PPAR-α but inhibits the activity of PPAR-γ.  Protein Kinase A 
(PKA) increases the activity of all PPAR isoforms.  PPAR isoforms are regulated by physiological changes 
leading to the production of kinase activators.    
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PPARs are short-lived proteins that are degraded in the ubiquitin-proteosome 
pathway as a regulation to its transcriptional activities (Blanquart et al., 2003).  The 
proteins degraded in this pathway are covalently modified on lysine residues by fixation of 
ubiquitins in a three-step process as shown in Figure 1.6.  First, ubiquitin is activated by a 
ubiquitin-activating enzyme.  The activated ubiquitin is subsequently transferred to a 
ubiquitin carrier protein.  Finally, ubiquitin-protein ligase catalyzes the covalent binding of 
ubiquitin from its carrier protein to the target protein.  Multi-ubiquitinated proteins are 
degraded by the 26S proteosome.  This system controls the PPAR protein levels in cells 
and also the intensity of a response to a ligand (Hauser et al., 2000; Blanquart et al., 2002).      
 
 
 
Figure 1.6 Possible mechanisms of PPAR degradation by the ubiquitin-proteosome 
system (Blanquart et al., 2003) 
PPAR proteins are degraded by the ubiquitin-proteosome pathway.  Ligand activated PPARs are stable due to 
decreased ubiquitination.  However, upon binding with co-factors, ubiquitination is increased again in order to 
control the response. 
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1.5.3 Isoforms of PPAR and its known functions 
PPAR has been implicated in several biological roles that include aging, immunity, 
obesity, cell cycle control and fertility (Youssef & Badr, 2004).  PPAR-α is mainly 
expressed in hepatocytes, enterocytes, smooth muscle cells, monocytes, macrophages, 
endothelial and kidney cells.  It is usually involved in lipid metabolism by hepatic cells. It 
regulates the uptake, binding, activation and oxidation of fatty acids, synthesis of ketone 
bodies and apolipoproteins, control of gluconeogenesis and deamination of amino acids 
(Bishop-Baily & Wray, 2003).   
PPAR-γ is found in brown and white tissue adipocytes.  It is mainly involved in 
adipocyte function and proliferation.  In humans, PPAR-γ might play a role in the 
differentiation of cells, the sensitization to insulin and atherogenesis.  PPAR-γ ligands have 
been reported to increase the adipose mass of humans in-vivo.  It also promotes the 
differentiation of macrophages into foam cells via the expression of CD36, which would 
lead to arteriosclerosis.  CD36 serves as a plasma membrane scavenger receptor for 
oxidized low-density lipoprotein (LDL).  On the other hand, PPAR-γ has been shown to 
inhibit the proliferation of human cancer cell cultures and represses the production of 
inflammatory cytokines (Bar-Tana, 2001).  In fertility, PPAR-γ appears to play an 
important role in the development of embryos (Cui et al., 2002; Yousef & Badr, 2004).     
No specific function has yet been identified for PPAR-δ although it has a wide 
distribution.  Research on the role of PPAR-δ is lacking, partially because specific ligands 
are not readily or commercially available.  PPAR-δ is involved in the control of cellular 
development and the pathogenesis of tumours such as in colorectal cancer (Rotondo & 
Davidson, 2002).  PPAR-δ knockout mice had been observed to be more susceptible in 
developing colon polyps when treated with azoxymethane compared to mice that express 
PPAR-δ (Harman et al., 2004).  The review by Yousef & Badr (2004) mentions a study in 
their group using a dual PPAR agonist (L783483), which activates PPAR-δ and γ.  
Treatment with the agonist caused a two-fold reduction in carrageenan-induced paw edema 
of rats, compared to rosiglitazone (a potent PPAR-γ agonist) alone.  This suggests that 
PPAR-δ may also play a role in modulating inflammation (Youssef & Badr, 2004).  PPAR-
δ/β had also been observed to play an important role in signaling pathways that leads to the 
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development of placenta in pregnant mice as mice with PPAR-δ/β  knockout genes exhibit 
embryonic growth retardation.  The important role of PPAR-δ/β has been identified in the 
differentiation and metabolic functions of giant trophoblast cells, which is essential for 
embryo implantation, remodeling of the uterine stroma and hormone secretion that 
promotes placenta formation (Nadra et al., 2006). 
 
1.6 PPAR and Immunity 
1.6.1 Role of PPAR-α 
Apart from transactivating genes, PPARs can trans-suppress inflammatory gene 
activation.  PPAR-α knockout mice have been shown to exhibit a prolonged inflammatory 
response when treated with LTB4.  LTB4 is a PPAR-α ligand that induces its own 
degradation by stimulating the β-oxidation pathway (Bishop-Bailey & Wray, 2003).  In an 
animal study by Cuzzocrea et al. (2006), the role of PPAR-α was observed in two types of 
acute inflammation (carrageenen induced paw edema and lung pleurisy).  In paw 
inflammation, mice with the PPAR-α knockout gene had significantly enhanced paw 
edema and higher myloperoxidase activity (indicator for polymorphonuclear (PMN) 
leukocyte accumulation) compared to wild type mice.  Histological studies of paw tissues 
observed significant pathological changes, which includes more inflammatory cell 
infiltration and higher staining for FAS ligand in PPAR-α knockout mice.  In lung 
inflammation, PPAR-α knockout mice had significantly higher pleural exudates and 
inflammatory cell infiltration (characterized by myeloperoxidase activity) in the lung 
compared to wild type mice.  Histological studies also indicate augmentation of lung tissue 
damage and higher FAS ligand staining in the vascular wall and pneumocytes of PPAR-α 
knockout mice.  Cytokine measurements detected a significantly higher level of IL-1 and 
TNF-α expression in lung tissue and pleural exudates of PPAR-α knockout mice.  The 
authors propose that PPAR-α modulates the degree of acute inflammation by reducing FAS 
ligand activation, suppressing the formation of pro-inflammatory cytokines and decreasing 
PMN leukocyte infiltration (Cuzzocrea et al., 2006).    
PPAR-α also inactivates NF-κB and represses the expression of inflammatory 
mediators induced by extracellular inflammatory stimuli like cytokine-induced Vascular 
